Skip to content

Effect of intraperitoneal infiltration with different concentrations of ropivacaine on postoperative pain in patients undergoing laparoscopic sleeve gastrectomy

Effect of intraperitoneal infiltration with different concentrations of ropivacaine on postoperative pain in patients undergoing laparoscopic sleeve gastrectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064219
Enrollment
Unknown
Registered
2022-09-30
Start date
2022-09-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute postoperative pain

Interventions

0.25% ropivacaine group: intraperitoneal infiltration with 0.25% ropivacaine
0.5% ropivacaine group : intraperitoneal infiltration with 0.5% ropivacaine
control group:intraperitoneal infiltration with0.9% normal saline

Sponsors

Beijing Shijitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective laparoscopic sleeve gastrectomy; 2. Age 18-60 years, both sexes; 3. BMI>= 28 kg/m2 ; 4. American Society of Anesthesiologists (ASA) Class I-III; 5. Patients and their family members agreed and signed informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with myocardial infarction, heart failure and cerebral infarction occurred in the past 1 month; 2. NYHA class III or above, severe valvular disease, ventricular arrhythmias and block; 3. Severe liver (Child-Pugh liver function grade C), renal insufficiency (serum creatinine level > 442µmol/L, or renal replacement therapy); 4. Severe anemia (Hb1.5) or hematological diseases; 6. Other types of bariatric surgery; 7. patients with allergic history to local anesthesia; 8. patients with communication and communication disorders; 9. Patients aged >65 years and <18 years; 10. Patients with ASA grade III or higher.

Design outcomes

Primary

MeasureTime frame
NRS pain score at 6 hours after surgery;

Secondary

MeasureTime frame
Pain score at 1h, 2h, 12h, 24h and 48h after operation;Sleep score (NRS) 1 and 2 days after surgery;The use of postoperative analgesic pump, and the dosage of remedial analgesic drugs;First time out of bed, first exhaust time, hospital stay;Postoperative adverse events;

Countries

China

Contacts

Public ContactPengfei Liu

Beijing Shijitan Hospital, Capital Medical University

sfflpf@126.com+86 15210626257

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026